Summary
This NIH funding opportunity (PAR-25-181) supports the development and testing of psychosocial therapeutic and preventive interventions for mental disorders through the R33 clinical trial mechanism. The R33 phase represents the later-stage, larger clinical trial component of a phased research award (typically following an R61 exploratory phase). Applicants must conduct a required clinical trial as part of their research plan. The opportunity is open from November 2024 through October 2027, suggesting multiple submission cycles.